We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Organizada pelo Governo Britânico, ocasião contou com a Embaixadora Stephanie Al-Qaq e o Diretor do Ministério Britânico de Ciência, Inovação e Tecnologia.
A summary of anticipated local/parish level adverse effects on ecological receptors in MA08.
A summary of anticipated local/parish level adverse effects on ecological receptors in MA06.
A summary of anticipated local/parish level adverse effects on ecological receptors in MA07.
A summary of anticipated local/parish level adverse effects on ecological receptors in MA04.
A summary of anticipated local/parish level adverse effects on ecological receptors in MA05.
This report details new or different local/parish level adverse effects since the main ES.
Recombinant human erythropoietin (r-HuEPO) treatment has been associated with very rare cases of life-threatening severe cutaneous adverse reactions (SCARs), including Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN). Withdraw r-HuEPOs permanently in patients who develop severe skin reactions such as...
Employment Tribunal decision.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).